Proprietary Program Classifies Broader Range of Cancer Risk Genes
A history-weighting algorithm has been shown to upgrade and downgrade variants of uncertain significance to more definitive clinical classifications, with high accuracy.
Read MorePosted by Elaine Sanchez Wilson | Apr 1, 2016 | Cancer, Molecular Diagnostics |
A history-weighting algorithm has been shown to upgrade and downgrade variants of uncertain significance to more definitive clinical classifications, with high accuracy.
Read MorePosted by Elaine Sanchez Wilson | Mar 24, 2016 | Information Technology, Molecular Diagnostics |
The functionality provides an intuitive interface and workflow for labs to systematically assess the disease-causing potential of genetic variants using clinical guidelines.
Read MorePosted by Elaine Sanchez Wilson | Mar 15, 2016 | Cerebrovascular, Molecular Diagnostics, Stroke |
The conclusion to our three-part series exploring the value of diagnostics.
Read MorePosted by Elaine Sanchez Wilson | Mar 14, 2016 | Cancer, Mass Spectrometry Reagents & Test Kits, Molecular Diagnostics |
Singapore General Hospital and Thermo Fisher Scientific are collaborating to study the mutational profiles of cancer patients with Asian ancestry.
Read MorePosted by Elaine Sanchez Wilson | Mar 8, 2016 | Prenatal Testing, Research |
In a clinical validation study, Sequenom’s laboratory-developed noninvasive prenatal test was shown to exhibit high resolution, sensitivity, and specificity.
Read More